Table 1

Clinical characterisation of included patients

	Age	Sex	Disease duration (y)	Antidementia medication	Duration of treatment (months)
Patient 1	64	Male	4	Donepezil 10 mg	41
Patient 2	55	Female	2	Donepezil 10 mg	22
Patient 3	62	Female	4	Donepezil 10 mg	38
Patient 4	56	Male	5	Rivastagmine 12 mg	49
Patient 5	55	Male	3	Donepezil 10 mg	32